The global DT-based combined vaccines market is anticipated to grow at a significant CAGR of 6.5% during the forecast period 2022-2028. The major factor which is attributing to the market growth is the rising awareness among people for vaccination against several diseases. The rise in cases of diphtheria and tetanus are constantly being seen. The major players of the market are adopting various strategies, including collaborations and mergers in order to remain competitive in the market and to develop new vaccines and medications. For Instance, in March 2021, Stablepharma Ltd. announced a collaboration with European vaccine manufacturer BB-NCIPD to develop a thermally stable version of the tetanus-diphtheria (Td) vaccine using the patented StablevaX formulation and device. According to World Health Organization (WHO), BB-NCIPD Ltd. is a supplier of around 9% of the global demand for Td vaccines in 2019. The global demand for the vaccine is estimated to be around 270 million doses and continues to grow mainly driven by WHO’s recommendation in 2015 of moving from Tetanus alone to the Td combination vaccine. WHO projects the demand to grow to 410 million doses by 2030.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/dt-based-combined-vaccines-market
Similarly, the Pharmaniaga Bhd had signed Memoranda of Understanding (MoU) with two biotechnology companies based in Thailand in February 2022, for vaccine, bioequivalence solutions as well as pharmaceutical products development.
Moreover, Dynavax Technologies Corp. and Serum Institute of India (SIIPL) had collaborated to address the shortcomings of the currently marketed acellular pertussis vaccines. Under the collaboration, Dynavax has exclusive worldwide rights to commercialize the vaccine, except that SII has exclusive rights to distribute in India and to fulfil WHO/UNICEF tender contracts. The parties are responsible for clinical development costs in their respective territories. In February 2021, both the companies had jointly announced that the first participant has been dosed in Phase 1 clinical trial evaluating tetanus, diphtheria, and acellular pertussis (Tdap) booster vaccine candidate adjuvanted with CpG 1018.
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
Segment Covered-
- By Type
- By Application
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape – including, Pfizer, Inc., Sanofi S.A., Novartis International AG, Bharat Biotech Ltd., GlaxoSmithKline PLC and others
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How are players addressing challenges to sustain growth?
- Where is the investment opportunity?
Global DT-Based Combined Vaccines Market Report Segment
By Type
- DTaP
- DTwP
By Application
- Paediatrics
- Adults
- Elderly
- Pregnancy
A full report of DT-Based Combined Vaccines Market is available at: https://www.omrglobal.com/industry-reports/dt-based-combined-vaccines-market
DT-Based Combined Vaccines Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Astellas Pharma US, Inc.
- BB-NCIPD Ltd.
- Bharat Biotech Ltd.
- Biological E Ltd.
- Emergent BioSolutions Inc.
- Protein Sciences Corp.
- Sanofi Pasteur (a subsidiary of Sanofi SA)
- Seqrius (a subsidiary of CSL Ltd.)
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
